SprosRadar
Find tenders
Tenders Electronic Daily (TED) · 789496-2026

Spain – Antineoplastic agents – Suministro sucesivo de diversos medicamentos para el tratamiento del mieloma múltiple con destino al Área Sanitaria de Santiago de Compostela e Barbanza.

Key facts

StatusAwarded
Estimated value€7,423,974.91
Submission deadlineDeadline not published
PublishedNov 13, 2026
BuyerServicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza
CountrySpain · Santiago de Compostela
CPV code33652100
SourceTenders Electronic Daily (TED) ↗
Open official notice
Status
Awarded
Estimated value
€7,423,974.91
Submission deadline
Deadline not published
Published
Nov 13, 2026
Buyer
Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza
Country
Spain
CPV code
33652100
Source
Tenders Electronic Daily (TED)

Contract outcome & evergreen alternatives

This notice is no longer open for submissions. The original remains available for reference.

Awarded supplier / winnerRegistration / LEI numberCountryAwarded contract amountAward date
AMGEN, S.A.
WORLD TRADE CENTER BARCELONA.MOLL DE BARCELONA,S/N EDIFIC. SUD 7ª PLANTA, BARCELONA, 08039
cs-es@amgen.com · 900850446
ES-REG: A59363655Spain€59,539,294.76Jul 28, 2026
JANSSEN-CILAG, S.A.
PASEO DE LAS DOCE ESTRELLAS 5-7, Madrid, 28042
ES-REG: A28925899Spain€59,539,294.76Jul 28, 2026
SANOFI AVENTIS
JOSEP PLA, 2, BARCELON, 08019
nuria.alsina@sanofi-aventis.com · 934859400
ES-REG: A08163586Spain€59,539,294.76Jul 28, 2026
PFIZER, S.L.U.
AVDA.EUROPA, 20-B PARQUE EMPRESARIAL LA MORALEJA, ALCOBENDAS, 28108
contabilidad.clientes@pfizer.com · 914909900
ES-REG: B28089225Spain€59,539,294.76Jul 28, 2026

Open tenders in this CPV category (CPV 33000000 · View CPV × country award matrix)

Checked:

The original notice takes precedence. Its status and conditions can change after collection.

Description

Suministro sucesivo de diversos medicamentos para el tratamiento del mieloma múltiple con destino al Área Sanitaria de Santiago de Compostela e Barbanza.

Lots

  1. CARFILZOMIB

    CARFILZOMIB

    €530,009.6

  2. DARATUMUMAB

    DARATUMUMAB

    €6,093,120.96

  3. ISATUXIMAB

    ISATUXIMAB

    €338,624.05

  4. ELRANATAMAB

    ELRANATAMAB

    €109,992.76

  5. TALQUETAMAB

    TALQUETAMAB

    €73,761.6

  6. TECLISTAMAB

    TECLISTAMAB

    €278,465.94

Public business contacts

contratacionadministrativa.ctra.santiago@sergas.es

+34 981950803

Checked: